由CIZ1缺失引起的表观遗传不稳定性在静止周期期间驱动转化
Olivia G Dobbs1,2, Rosemary H C Wilson3,4, Katherine Newling3,5
1Department of Biology, University of York, York, YO10 5DD, UK. grace.dobbs@york.ac.uk.
BMC biology
|August 14, 2023
概括
失去CIZ1蛋白质会影响细胞静止期间的核凝结,导致基因组不稳定性和潜在的癌症发展. 这突出了CIZ1的特点.
科学领域:
- 表观遗传学和染色体生物学
- 细胞循环规则 细胞循环规则
- 癌症生物学 癌症生物学
背景情况:
- 与Cip1相互作用的指蛋白1 (CIZ1) 稳定表观遗传状态,特别是在不活跃的X染色体.
- CIZ1功能障碍与人类癌症有关,并导致雌性小鼠的淋巴细胞增生.
- 这表明CIZ1在表观遗传稳定性和疾病发病过程中的作用之间存在联系.
研究的目的:
- 研究CIZ1在细胞静止期间的染色质凝聚中的作用.
- 确定CIZ1缺陷对核完整性和基因组稳定性的后果.
- 探索CIZ1损失和癌症发展之间的潜在联系.
主要方法:
- 分析CIZ1-null小鼠纤维细胞的H4K20me1水平和核凝结.
- 评估与染色体凝聚和DNA修复相关的基因表达.
- 对SET8 (H4K20me1甲基转移酶) 和CIZ1再表达的实验操纵.
主要成果:
- 在进入静止状态时,CIZ1-null细胞表现出减少的H4K20me1和受损的核凝结.
- 虽然保持了全球转录,但影响了参与染色质凝聚和DNA修复的基因.
- 在CIZ1缺乏的细胞中,重复的静止周期会导致核扩张,DNA损伤和转化.
结论:
- 在静态进入过程中,CIZ1对于适当的染色质凝聚至关重要.
- 失去CIZ1会损害表观基因组,导致静止周期期间基因组不稳定.
- 缺少CIZ1代表了细胞经历反复静止的脆弱性,可能导致癌症.
相关概念视频
03:17Inheritance of Chromatin Structures
6.3K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.3K
01:37Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
01:58X-Inactivation
38.8K
The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results.
38.8K
01:32Chromatin Modification in iPS Cells
1.7K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.7K
01:29Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K